Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting

NCT ID: NCT06637982

Last Updated: 2024-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-10

Study Completion Date

2025-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thirty two healthy implants will be selected from the outpatient clinic of the oral and maxillofacial department of Mansoura university to be included in this study for replacement of lost posterior teeth with limited bone width.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ridge Splitting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ridge splitting with allograft and pericardium membrane

Group Type EXPERIMENTAL

ridge splitting with the use of allograft and pericardium membrane

Intervention Type PROCEDURE

ridge splitting with the use of allograft and pericardium membrane

ridge splitting with extended platelet rich fibrin

Group Type EXPERIMENTAL

ridge splitting with the use of extended platelet rich fibrin

Intervention Type PROCEDURE

ridge splitting with the use of extended platelet rich fibrin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ridge splitting with the use of allograft and pericardium membrane

ridge splitting with the use of allograft and pericardium membrane

Intervention Type PROCEDURE

ridge splitting with the use of extended platelet rich fibrin

ridge splitting with the use of extended platelet rich fibrin

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age 18 years old and older.
* Patient's cooperation, motivation and good oral hygiene.
* Atrophic posterior mandible of horizontal alveolar dimension range between 3 - 6 mm at the crest, with minimum 10 mm vertical height from the alveolar crest to the superior border of the inferior alveolar canal.
* Absence of undercuts in buccal aspect of the ridge.
* Favorable occlusion and no parafunctional habits.
* Patients able to comply with the required recall visits.
* No gender preface in selection of the patients.
* Acceptable inter-arch space for the future prosthesis.

Exclusion Criteria

* Any pathological condition at the site of surgery.
* Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
* Patient taking drugs that could affect bone healing process as immunosuppressive drugs and bisphosphonates.
* Heavy smoking and alcoholism.
* Parafunctional habits such as bruxism and clenching.
* Signs of acute infection or pus discharge.
* Untreated periodontal disease or bad oral hygiene.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura University

Mansoura, Egypt, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

faisal alshammri

Role: CONTACT

1555250898 ext. 0020

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

faisal alshammri

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A0302024OS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autogenous Tooth Graft for Ridge Augmentation
NCT06416605 ACTIVE_NOT_RECRUITING NA